4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-010606
Chief Financial Officer bought 3,657 shares at $4.10 ($14,994)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patience David Chief Financial Officer | 2026-02-23 | Purchase | +3,657 | $4.10 | $14,994 | 268,657 | D |
| Open-market purchases · 3,657 sh · avg $4.10 · $14,994 | |||||||
Loading xslF345X05/wk-form4_1771880906.xml…